Reports Q2 revenue $265.4M, consensus $201.97M. Cash and cash equivalents were $108.1M as of June 30, , which does not include the $90M milestone payment from Pfizer that is expected to be received in August 2023.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on OPK:
